Related references
Note: Only part of the references are listed.Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cleavage and phosphorylation: important post-translational modifications of galectin-3
Xiaoge Gao et al.
CANCER AND METASTASIS REVIEWS (2017)
Galectin 3 as a guardian of the tumor microenvironment
Peter P. Ruvolo
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression
Lei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo
Ladan Delphi et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells
Nashwa M. Abu-Elsaad et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Modified sugar beet pectin induces apoptosis of colon cancer cells via an interaction with the neutral sugar side-chains
Ellen G. Maxwell et al.
CARBOHYDRATE POLYMERS (2016)
Structural elucidation of a pectin from flowers of Lonicera japonica and its antipancreatic cancer activity
Liyan Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Multiple approaches to assess pectin binding to galectin-3
Tao Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
Ana Carolina Ferreira Cardoso et al.
FRONTIERS IN ONCOLOGY (2016)
Pectic-Oligoshaccharides from Apples Induce Apoptosis and Cell Cycle Arrest in MDA-MB-231 Cells, a Model of Human Breast Cancer
Ladan Delphi et al.
Asian Pacific Journal of Cancer Prevention (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma
Masoud Zeinali et al.
HUMAN IMMUNOLOGY (2015)
Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy
Yugo Mori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors
A. Menachem et al.
CELL DEATH DISCOVERY (2015)
Galectin-3 as a Potential Target to Prevent Cancer Metastasis
Hafiz Ahmed et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2015)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
Christina Yeung et al.
PHARMACOECONOMICS (2014)
Synergistic Effects of PectaSol-C Modified Citrus Pectin an Inhibitor of Galectin-3 and Paclitaxel on Apoptosis of Human SKOV-3 Ovarian Cancer Cells
Ghamartaj Hossein et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Anti-cancer activities of pH- or heat-modified pectin
Lionel Leclere et al.
FRONTIERS IN PHARMACOLOGY (2013)
Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus Pectin
Cheppail Ramachandran et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
Maria Kolatsi-Joannou et al.
PLOS ONE (2011)
Galectin-3 expression is associated with bladder cancer progression and clinical outcome
Giacomo Canesin et al.
TUMOR BIOLOGY (2010)
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
Vladislav V. Glinsky et al.
CARBOHYDRATE RESEARCH (2009)
Recognition of galactan components of pectin by galectin-3
A. Patrick Gunning et al.
FASEB JOURNAL (2009)
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model
Hai-Ying Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia
Kim D. Johnson et al.
NEOPLASIA (2007)
Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure
Crystal L. Jackson et al.
GLYCOBIOLOGY (2007)
Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells
N Oka et al.
CANCER RESEARCH (2005)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents
P Nangia-Makker et al.
TRENDS IN MOLECULAR MEDICINE (2002)
De novo muscle invasive bladder cancer: Is there a change in trend?
A Vaidya et al.
JOURNAL OF UROLOGY (2001)